Benitec Biopharma (BNTC) Stock Highlights

10.49 | +2.84%

2024-11-23 05:31:35

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.

Statistics

Range Today

9.88 10.49

Volume Today 22.3K

Range 1 Year

2.69 12.89

Volume 1 Year 10.52M

Range 3 Year

1.86 56.78

Volume 3 Year 74.67M

Range 10 Year

1.86 4202.4

Volume 10 Year 89.77M

Highlights

Market Capitalization 209.64M (small)

Floating Shares 3.88M

Current Price 10.49

Price To Earnings -1.97

Price To Book 2.26

Earnings Per Share -5.33

Payout Ratio 0%

Performance

Latest +2.84%

1 Month -5.07%

3 Months +16.69%

6 Months +4.48%

1 Year +193.02%

3 Years -81.07%

5 Years -93.14%

10 Years -99.69%

Benchmarks

Market Capitalization

341 / 368

Gross Profits

148 / 278

Total Revenue

274 / 300

Total Rank

295 / 368

Free Cashflow

98 / 352

Performance 5 years

303 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.